Josef Hoefler

456 total citations
9 papers, 336 citations indexed

About

Josef Hoefler is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Josef Hoefler has authored 9 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Josef Hoefler's work include Biosimilars and Bioanalytical Methods (3 papers), Neutropenia and Cancer Infections (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Josef Hoefler is often cited by papers focused on Biosimilars and Bioanalytical Methods (3 papers), Neutropenia and Cancer Infections (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Josef Hoefler collaborates with scholars based in Germany, United States and Belgium. Josef Hoefler's co-authors include Donna P. Ankerst, Ian M. Thompson, Robin J. Leach, John T. Wei, Martin G. Sanda, Phyllis J. Goodman, Andrew J. Vickers, Javier Hernández, Lori J. Sokoll and S. De Bock and has published in prestigious journals such as Blood, Diabetologia and European Urology.

In The Last Decade

Josef Hoefler

9 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josef Hoefler Germany 5 196 68 67 65 54 9 336
H.K. Tsai United States 3 289 1.5× 146 2.1× 38 0.6× 71 1.1× 33 0.6× 20 401
Annamaria Del Franco Italy 12 69 0.4× 22 0.3× 139 2.1× 50 0.8× 65 1.2× 41 501
Anne Hickman United States 13 38 0.2× 201 3.0× 132 2.0× 60 0.9× 94 1.7× 32 360
Amy N. Sussman United States 9 172 0.9× 7 0.1× 41 0.6× 29 0.4× 33 0.6× 20 346
D Pestalozzi Switzerland 10 107 0.5× 34 0.5× 74 1.1× 29 0.4× 67 1.2× 12 328
Michael Z. Liao United States 12 44 0.2× 24 0.4× 70 1.0× 180 2.8× 13 0.2× 24 384
Toshihisa Tomoda Japan 11 94 0.5× 33 0.5× 66 1.0× 91 1.4× 99 1.8× 38 310
Pierre Costa France 5 164 0.8× 180 2.6× 71 1.1× 22 0.3× 25 0.5× 5 344
Maja Tarp Denmark 3 107 0.5× 23 0.3× 82 1.2× 71 1.1× 157 2.9× 4 325

Countries citing papers authored by Josef Hoefler

Since Specialization
Citations

This map shows the geographic impact of Josef Hoefler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Hoefler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Hoefler more than expected).

Fields of papers citing papers by Josef Hoefler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Hoefler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Hoefler. The network helps show where Josef Hoefler may publish in the future.

Co-authorship network of co-authors of Josef Hoefler

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Hoefler. A scholar is included among the top collaborators of Josef Hoefler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Hoefler. Josef Hoefler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Blüher, Matthias, Julio Rosenstock, Josef Hoefler, Raymond C. Manuel, & Anita M. Hennige. (2023). Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial. Diabetologia. 67(3). 470–482. 67 indexed citations
3.
4.
Wessels, Hendrik, et al.. (2020). Pelmeg®, a biosimilar pegfilgrastim developed in the context of evolving regulatory guidelines. Generics and Biosimilars Initiative Journal. 9(3). 125–131. 2 indexed citations
5.
Braud, Filippo de, Jean‐Pascal Machiels, Daniela Boggiani, et al.. (2020). A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors. Cancers. 12(6). 1425–1425. 4 indexed citations
6.
Wessels, Hendrik, et al.. (2017). Comparability of Pharmacodynamics and Immunogenicity of B12019, a Proposed Pegfilgrastim Biosimilar to Neulasta. Blood. 130. 1002–1002. 4 indexed citations
7.
Ankerst, Donna P., et al.. (2015). A case control study of sarcosine as an early prostate cancer detection biomarker. BMC Urology. 15(1). 99–99. 32 indexed citations
8.
Ankerst, Donna P., Jing Xia, Ian M. Thompson, et al.. (2015). Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary–Early Detection Research Network Active Surveillance Biopsy Risk Calculator. European Urology. 68(6). 1083–1088. 35 indexed citations
9.
Ankerst, Donna P., Josef Hoefler, S. De Bock, et al.. (2014). Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer. Urology. 83(6). 1362–1368. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.K. Tsai Breakdown of academic impact, for papers by Annamaria Del Franco Breakdown of academic impact, for papers by Anne Hickman Breakdown of academic impact, for papers by Amy N. Sussman Breakdown of academic impact, for papers by D Pestalozzi Breakdown of academic impact, for papers by Michael Z. Liao Breakdown of academic impact, for papers by Toshihisa Tomoda Breakdown of academic impact, for papers by Pierre Costa Breakdown of academic impact, for papers by Maja Tarp
Rankless by CCL
2026